Аспекты патогенеза и особенности клинического течения эректильной дисфункции у больных с метаболическим синдромом
Аспекты патогенеза и особенности клинического течения эректильной дисфункции у больных с метаболическим синдромом
Мазо Е.Б., Гамидов С.И., Гасанов Р.В. Аспекты патогенеза и особенности клинического течения эректильной дисфункции у больных с метаболическим синдромом. Consilium Medicum. 2008; 10 (2): 62–65.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Список литературы
1. Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study.
J Urol 1994; 151: 151–4.
2. Nicolosi A, Moreira ED Jr, Shirai M et al. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003; 61: 201–6.
3. NIH Consensus development conference statement. NIH consensus development panel on impotence. Int J Impot Res 1993; 4: 181–284.
4. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5–11.
5. Parazzini F, Menchini FF, Bortolotti A et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol 2000; 37: 43–9.
6. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607.
7. Gunduz MI, Gumus BH, Sekuri C. Relationship between metabolic syndrome and erectile dysfunction. Asian J Androl 2004; 6(4): 355–8.
8. Esposito K, Giugliano F, Martedi E et al. High proportions of erectile dysfunction in men with the metabolic syndrome, Diabetes Care 2005; 28(5): 1201–3.
9. Demir T, Demir O, Kefi A et al. Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol 2006; 13(4): 385–58.
J Urol 1994; 151: 151–4.
2. Nicolosi A, Moreira ED Jr, Shirai M et al. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003; 61: 201–6.
3. NIH Consensus development conference statement. NIH consensus development panel on impotence. Int J Impot Res 1993; 4: 181–284.
4. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5–11.
5. Parazzini F, Menchini FF, Bortolotti A et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol 2000; 37: 43–9.
6. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607.
7. Gunduz MI, Gumus BH, Sekuri C. Relationship between metabolic syndrome and erectile dysfunction. Asian J Androl 2004; 6(4): 355–8.
8. Esposito K, Giugliano F, Martedi E et al. High proportions of erectile dysfunction in men with the metabolic syndrome, Diabetes Care 2005; 28(5): 1201–3.
9. Demir T, Demir O, Kefi A et al. Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol 2006; 13(4): 385–58.
Авторы
Е.Б.Мазо, С.И.Гамидов, Р.В.Гасанов
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.